Evolution of COVID-19 in patients with autoimmune rheumatic diseases

Author:

Pang Rongrong12,Zhao Jun13,Gan Zhenhua45,Hu Zhiliang67,Xue Xiang8,Wu Yanjun910,Qiao Qinghua1112,Zhong Aifang1213,Xia Xinyi1512,Liao Hui14,Wang Zhihua51215,Zhang Libo12

Affiliation:

1. COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, The First School of Clinical Medicine, Southern Medical University, Nanjing 210002, Jiangsu, China

2. Department of Laboratory Medicine, Nanjing Red Cross Blood Center, Nanjing 210003, Jiangsu, China

3. Graduate School, Nanjing Medical University, Nanjing 211166, Jiangsu, China

4. Department of Medical Administration, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China

5. Joint Expert Group, Wuhan Huoshenshan Hospital, Wuhan 430100, Hubei, China

6. Nanjing Infectious Disease Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing 210003, Jiangsu, China

7. School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, China

8. Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM 87131, USA

9. Department of Information, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China

10. Department of Information, Wuhan Huoshenshan Hospital, Wuhan 430100, Hubei, China

11. Medical and Technical Support Department, Pingdingshan Medical District, The 989th Hospital, Pingdingshan 467000, Henan, China

12. Department of Laboratory Medicine and Blood Transfusion, Wuhan Huoshenshan Hospital, Wuhan 430100, Hubei, China

13. Medical Technical Support Division, Changzhou Medical District, The 904th Hospital, Changzhou 213003, Jiangsu, China

14. Department of Hematology, The Air Force Hospital from Eastern Theater of PLA, Nanjing 210002, Jiangsu, China

15. Department of Laboratory Medicine and Blood Transfusion, The 907th Hospital, Nanping 350702, Fujian, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3